Voting Results pursuant to Regulation 44 and information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015

1. Intimation for appointment of Mr. Balavenkatarama Prasad Suryadevara (DIN: 02699949) as Additional Director in the capacity of Executive Whole-Time Director of the Company w.e.f. 31st July, 2023 2. Resignation of Mr. Raajan Kumar Ailawadhi (DIN: 08821964) from the position of Whole-Time Director of the Company w.e.f. 31st July, 2023

Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the first quarter ended June 30, 2023

Intimation of Book Closure for the purpose of Dividend

Press Release Q1 FY24

We wish to inform you that pursuant to Regulations 30 and 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 the 63rd (Sixty Third) Annual General Meeting ("AGM") of the Company is scheduled to be held on Tuesday, August 22, 2023 at 12:00 noon IST through Video Conferencing ("VC")/Other Audio Visual Means ("OAVM"). Please find enclosed herewith the Annual Report for the financial year 2022-23 including Notice convening AGM, which has been sent to the members today i.e. July 31, 2023.

Announcement under Regulation 30 (LODR) - Raising of Funds.

Scrutinizer''s report of the Extra-ordinary general meeting held on July 31, 2023

As per Attachment

Geecee Ventures Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 ,inter alia, to consider and approve This is to inform you that pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, meeting of the Board of Directors of the Company is scheduled to be held on Monday August 07, 2023 interalia to : 1. Consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2023. 2. Any other matter with the permission of Chair.